TABLE 1.

Restenosis trial results

Author (reference)	Patients (n)	Comparator (%)	Restenosis cilostazol	Restenosis control (%)	P
Take et al (19)	68	ASA or ticlopidine	17	40	<0.05
Kozuma et al (21)	130	Ticlopidine	16	33	<0.0001
Tsuchikane et al (22)	211	ASA	18	40	<0.0001
Park et al (23)	409	Ticlopidine	23	27	NS
Ge et al (31)	397	Ticlopidine	29	37	0.086
Sekiya et al (24)	126	Placebo	32	12	<0.05
Douglas et al (26)	705	Placebo	34	22	0.0021

ASA Acetylsalicylic acid; NS Not significant